Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study.
Lung Cancer
; 100: 38-44, 2016 10.
Article
de En
| MEDLINE
| ID: mdl-27597279
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Quinazolines
/
Carcinome pulmonaire non à petites cellules
/
Score de propension
/
Chlorhydrate d'erlotinib
Type d'étude:
Observational_studies
/
Risk_factors_studies
Limites:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Lung Cancer
Sujet du journal:
NEOPLASIAS
Année:
2016
Type de document:
Article
Pays d'affiliation:
Suisse
Pays de publication:
Irlande